Coeptis Therapeutics Inc (COEP) — Cash Flow Quality Index

Latest as of December 2004: 0.59x

Coeptis Therapeutics Inc (COEP) has a Cash Flow Quality Index of 0.59x as of December 2004. Operating cash flow of $1.55 Million is below net income of $2.65 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Coeptis Therapeutics Inc cash flow conversion to assess how effectively this company generates cash.

Cash Flow Quality Index

0.59x
Operating CF / Net Income

Operating Cash Flow

$1.55 Million
USD

Net Income

$2.65 Million
USD

Data as of

Dec 2004
Most recent filing

Coeptis Therapeutics Inc Cash Flow Quality Index (2004–2004)

Historical Cash Flow Quality Index for Coeptis Therapeutics Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check COEP cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.

Annual Cash Flow Quality Index for Coeptis Therapeutics Inc (2004–2004)

Year-by-year earnings quality comparison for Coeptis Therapeutics Inc. For live market cap and the full company financial profile, see Coeptis Therapeutics Inc market capitalisation.

Year Quality Index Operating CF (USD) Net Income YoY Change
2004 0.59x $1.55 Million $2.65 Million
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.